ACRL:LSE-Accrol Group Holdings PLC (GBX)

COMMON STOCK | Household & Personal Products | LSE

Last Closing Price

GBX 24.75

Change

-0.45 (-1.79)%

Market Cap

GBX 0.08B

Volume

0.03M

Avg Analyst Target

N/A

Avg User Target

GBX
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


ACRL Stock Forecast & Price:
Based on the Accrol Group Holdings PLC stock forecasts from 0 analysts, the average analyst target price for Accrol Group Holdings PLC is not available over the next 12 months. Accrol Group Holdings PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Accrol Group Holdings PLC is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Accrol Group Holdings PLC’s stock price was GBX 24.75. Accrol Group Holdings PLC’s stock price has changed by -1.79% over the past week, -1.00% over the past month and -47.12% over the last year.

About Accrol Group Holdings PLC (ACRL:LSE)

Accrol Group Holdings plc engages in the soft tissue paper converting business in the United Kingdom and Europe. The company manufactures and sells private label toilet tissue, kitchen towels, and facial tissues, as well as biodegradable wet wipes. It serves discounters and groce ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-06-28 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ULVR:LSE Unilever PLC

+8.00 (+0.21%)

GBX95.26B 1,876.38 10.49
RB:LSE Reckitt Benckiser Group plc

N/A

GBX46.33B 39.07 12.01
PZC:LSE PZ Cussons PLC

-0.50 (-0.25%)

GBX0.86B 222.92 9.98
W7L:LSE Warpaint London PLC

+0.50 (+0.39%)

GBX0.10B 3,237.50 11.73
CRL:LSE Creightons Plc

N/A

GBX0.03B 9.60 6.95
SKIN:LSE DeepVerge plc

N/A

GBX0.03B N/A N/A
MCB:LSE McBride plc

-0.15 (-0.91%)

GBX0.03B 6.13 18.10
BAR:LSE Brand Architekts Group plc

+1.00 (+1.89%)

GBX0.01B 12.29 1.52
BYOT:LSE Byotrol Plc

N/A

GBX0.01B 23.00 28.92
IDP:LSE InnovaDerma PLC

N/A

GBX8.14M 8.21 5.12

ETFs Containing ACRL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Household & Personal Products)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -26.88% 67% D+ 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.88% 67% D+ 25% F
Trailing 12 Months  
Capital Gain -46.25% 44% F 10% F
Dividend Return 0.01% 40% F 15% F
Total Return -46.24% 44% F 9% F
Trailing 5 Years  
Capital Gain -83.64% 38% F 6% F
Dividend Return 5.10% 50% F 27% F
Total Return -78.55% 38% F 7% F
Average Annual (5 Year Horizon)  
Capital Gain 12.09% 67% D+ 67% D+
Dividend Return 0.29% 17% F 24% F
Total Return 12.37% 56% F 65% D
Risk Return Profile  
Volatility (Standard Deviation) 60.53% 33% F 23% F
Risk Adjusted Return 20.44% 56% F 44% F
Market Capitalization 0.08B 67% D+ 25% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Household & Personal Products)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 150.67 44% F 10% F
Price/Book Ratio 0.97 78% C+ 59% F
Price / Cash Flow Ratio 4.58 78% C+ 61% D-
EV/EBITDA 15.91 33% F 28% F
Management Effectiveness  
Return on Equity -7.62% 44% F 21% F
Return on Invested Capital -0.80% 33% F 36% F
Return on Assets 0.35% 56% F 29% F
Debt to Equity Ratio 11.35% 100% A+ 79% C+
Technical Ratios  
Dividend Yield 2.08% 57% F 44% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.87 44% F 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector